Y-Intercept (HK)’s Avanos Medical AVNS Stock Holding History

Y-Intercept (HK)’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.21M	Buy	+88,958	New	+$2.08M	0.04%	642
2026 Q1	–	Sell	-40,675	Closed	-$457K	–	1548
2025 Q4	$457K	Buy	40,675 +6,259	+18%	+$71.6K	0.01%	1257
2025 Q3	$398K	Sell	34,416 -45,657	-57%	-$535K	0.01%	1317
2025 Q2	$980K	Buy	80,073 +54,373	+212%	+$684K	0.02%	946
2025 Q1	$368K	Buy	+25,700	New	+$401K	0.03%	835
2024 Q3	–	Sell	-10,436	Closed	-$208K	–	1304
2024 Q2	$208K	Buy	+10,436	New	+$203K	0.01%	1170

Other funds holding AVNS

Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return

FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return